Back Home

Consortium of Canadian Centres for Clinical Cognitive Research

Consortium of Canadian Centres for Clinical Cognitive Research

  • Home
  • About
    • About C5R
    • Upcoming Events
    • Awards
      • Recipients…
        • 2020 – Dr. Krista Lanctôt
        • 2019 – Dr. Angeles Garcia
        • 2018 – Dr. Guy Lacombe
        • 2017 – Dr. Michael Borrie
        • 2016 – Dr. Jenny Ingram
        • 2015 – Dr. Ron Keren
        • 2014 – Dr. Rémi Bouchard
        • 2013 – Dr. Howard Feldman
        • 2012 – Dr. Kenneth Rockwood
        • 2011 – Dr. Sandra E. Black
        • 2010 – Dr. David Hogan
        • 2008 – Dr. Serge Gauthier
        • 2007 – Dr. Howard Chertkow
        • 2006 – Dr. Lynn Beattie
        • 2005 – Dr. Andrew Kertesz
    • Affiliate Organizations
  • Research
    • C5R Site Locations
    • Current Studies
    • How Drugs Are Approved in Canada
    • How to conduct trials with C5R
  • Contact
  • Log in

Current Studies

  • Alzheimer’s Disease Trials (AD)

Alzheimer’s Disease Trials (AD)


The following are ongoing Alzheimer’s Disease clinical trials in Canada:


Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer’s Disease (COGNITE)


A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer’s Disease


A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer’s Disease_ (MissionAD2)


Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer’s Disease (AD)


A Study of LY3303560 in Participants With Early Symptomatic Alzheimer’s Disease


A Study of LY3002813 and LY3202626 in Participants With Early Symptomatic Alzheimer’s Disease (TRAILBLAZER-ALZ)


A Study to Evaluate the Efficacy and Safety of RO7105705 in Patients With Prodromal to Mild Alzheimer’s Disease


Safety, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer’s Disease (BUENA)

 

QuestionPro provides unparalleled insights and just launched enterprise features including Communities, Customer Experience, Workforce and Mobile.

© 2021 C5R